Intravitreal Anti-VEGF Drugs as Adjuvant Therapy in Diabetic Retinopathy Surgery

E-ISSN： 1875-6417|7|3|176-184

ISSN： 1573-3998

Source： Current Diabetes Reviews, Vol.7, Iss.3, 2011-05, pp. : 176-184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy

By Simó R.

Diabetologia, Vol. 51, Iss. 9, 2008-09 ,pp. : 1574-1580

Springer Publishing Company

Access to resources Recommend Favorite

Anti-angiogenic Drugs as an Adjunctive Therapy in the Surgical Treatment of Diabetic Retinopathy

Current Diabetes Reviews, Vol. 5, Iss. 1, 2009-02 ,pp. : 52-56

Bentham Science Publishers

Access to resources Recommend Favorite

Intravitreal Triamcinolone in Diabetic Retinopathy

Current Diabetes Reviews, Vol. 5, Iss. 1, 2009-02 ,pp. : 18-25

Bentham Science Publishers

Access to resources Recommend Favorite

Intravitreal Bevacizumab for Diabetic Retinopathy

Current Diabetes Reviews, Vol. 5, Iss. 1, 2009-02 ,pp. : 39-46

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-VEGF Anticancer Drugs: Mind the Hypertension

Recent Patents on Cardiovascular Drug Discovery, Vol. 9, Iss. 2, 2014-12 ,pp. : 63-72

Bentham Science Publishers

Access to resources Recommend Favorite